Work

Real‐Life Effectiveness of Abrocitinib and Predictors of Response in Adults With Moderate‐To‐Severe Atopic Dermatitis

Year: 2026

Type: article

Abstract: Valeria Falcomatà has conflicts of interest with AbbVie and Johnson&Johnson. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Source: International Journal of Dermatology

DOI: 10.1111/ijd.70263

Authors: Eugenia Veronica Di Brizzi, Stefano Caccavale, Graziella Babino, Rocco De Pasquale, Valeria Falcomatà, Claudia Giofrè, Giampiero Mazzocchetti, Pietro Morrone, Giovanni Palazzo, Anna Balato

Institutions: University of Campania "Luigi Vanvitelli", University of Basilicata, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco", Azienda ospedaliera "Bianchi-Melacrino-Morelli", Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte, Azienda USL di Pescara, Azienda Sanitaria Provinciale di Cosenza

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W7123534352

FWCI: 13.02

Cites: 5

Cited by: 2

Related to: